Dividing T cells: A potential target for improving cancer immunotherapy
When an immune T cell divides into two daughter cells, the activity of an enzyme called mTORC1, which controls protein production, splits unevenly between the progeny, producing two cells with different properties. Such "asymmetric ...
Jul 01, 2016
0
213